Evaluation of bacille Calmette-Gu érin immunisation programs in Australia.
Conclusions: BCG immunisation programs aim to prevent severe forms of tuberculosis in young children who live in or travel to high burden settings. A range of factors, particularly inconsistent vaccine supply are leading to low, variable and inequitable vaccine delivery across Australian jurisdictions. Improved BCG vaccination uptake and AEFI data quality are required for accurate monitoring of program delivery and vaccine safety - this is particularly important given the current need to use unregistered vaccines. Improved and consistent access to BCG vaccine is suggested to optimise equity for at-risk children Australia-w...
Source: Communicable Diseases Intelligence Quarterly Report - April 8, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Community-acquired syndromes causing morbidity and mortality in Australia 
.
Conclusion: SSTI, CAP, and pyelonephritis are common syndromes responsible for admission to hospital in Australia, with an incidence that increases with age. CAP is a major cause of morbidity and mortality in the Australian population. Influenza is associated with the greatest percentage of severe infections requiring intensive care unit admission. PMID: 28385138 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - April 8, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Australian Gonococcal Surveillance Programme annual report, 2015.
Authors: Lahra MM, Enriquez RP, National Neisseria Network Abstract The Australian Gonococcal Surveillance Programme (AGSP) has continuously monitored antimicrobial resistance in clinical isolates of Neisseria gonorrhoeae from all Australian states and territories since 1981. In 2015, there were 5,411 clinical isolates of gonococci from public and private sector sources tested for in vitro antimicrobial susceptibility by standardised methods. Current treatment recommendations for the majority of Australian states and territories is a dual therapeutic strategy of ceftriaxone and azithromycin. Decreased susc...
Source: Communicable Diseases Intelligence Quarterly Report - April 8, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Immunisation coverage annual report, 2014.
This report includes coverage data for 'fully immunised' and by individual vaccines at standard age milestones and timeliness of receipt at earlier ages according to Indigenous status. Overall, 'fully immunised' coverage has been mostly stable at the 12- and 24-month age milestones since late 2003, but at 60 months of age, it has increased by more than 10 percentage points since 2009. As in previous years, coverage for 'fully immunised' at 12 months of age among Indigenous children was 3.7% lower than for non-Indigenous children overall, varying from 6.9 percentage points in Western Australia to 0.3 of a percentage point i...
Source: Communicable Diseases Intelligence Quarterly Report - April 8, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

OzFoodNet quarterly report, 1 October to 31 December 2014.
Authors: OzFoodNet Working Group PMID: 28385141 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - April 8, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

National Notifiable Diseases Surveillance System, 1 October to 31 December 2016.
Authors: PMID: 28385142 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - April 8, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Australian childhood immunisation coverage, 1 July 2015 and 30 June 2016 cohort, assessed as at 30 September 2016.
Authors: Hendry AJ PMID: 28385143 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - April 8, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016 
.
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016
. Commun Dis Intell Q Rep. 2017 Mar 31;41(1):E109-E110 Authors: Lahra MM, Enriquez RP, Prince of Wales Hospital, Randwick, for The National Neisseria Network PMID: 28385144 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - April 8, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

The Australian Sentinel Practices Research Network, 1 October to 31 December 2016.
Authors: Chilver MB, Blakeley D, Stocks NP, Australian Sentinel Practices Research Network
 PMID: 28385145 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - April 8, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Invasive Pneumococcal Disease Surveillance, 1 October to 31 December 2016 
.
Invasive Pneumococcal Disease Surveillance, 1 October to 31 December 2016
. Commun Dis Intell Q Rep. 2017 Mar 31;41(1):E114-E119 Authors: Pennington K, and the Enhanced Invasive Pneumococcal Disease Surveillance Working Group, for the Communicable Diseases Network Australia PMID: 28385146 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - April 8, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Influenza surveillance in Australia.
Authors: Pennington K, Bareja C, Sullivan SG, Franklin LJ, Raupach J PMID: 28278403 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - March 11, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Infectious diseases notification practices, Victoria 2013.
DISCUSSION: DHHS Victoria handles a large volume of infectious disease notifications. Incomplete Indigenous status reporting, particularly for conditions without active follow-up, and delayed notification of conditions requiring immediate attention warrant attention. These findings will be used to improve notification practices in Victoria. Commun Dis Intell 2016;40(3):E317-E325. PMID: 28278404 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - March 11, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

The Australian Master of Applied Epidemiology Program: Looking back, moving forward.
Authors: Davis S, Patel MS, Fearnley E, Viney K, Kirk M Abstract The Master of Applied Epidemiology Program is Australia's Field Epidemiology Training Program. It was established in 1991 and was run out of the National Centre for Population Health (NCEPH) at the Australian National University. The Program has a strong track record in using field-based training to produce competent applied epidemiologists who have contributed to public health in Australia and globally. A new funding model for the program was implemented in 2012, backed by funds from field placement partners and NCEPH. In this paper we revie...
Source: Communicable Diseases Intelligence Quarterly Report - March 11, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
CONCLUSIONS: Six MDR-TB cases were treated in the Northern Territory; 5 of these were notified by the NT CDC during the study period (1.5% of all Northern Territory TB notifications). The median age of all 6 patients was 31 years (range 21 to 50 years), sex distribution was equal and all were born overseas. Country of birth in a World Health Organization (WHO) high burden MDR-TB country and previous treatment were most highly correlated with a current diagnosis of MDR-TB. Access to rapid drug susceptibility testing reduced the time to effective therapy from 45 to 27 days. Five patients met criteria for the WHO outcome term...
Source: Communicable Diseases Intelligence Quarterly Report - March 11, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Influenza vaccination coverage among pregnant Indigenous women in the Northern Territory of Australia.
Authors: Moberley SA, Lawrence J, Johnston V, Andrews RM Abstract Pregnant Aboriginal and Torres Strait Islander women are at particular risk of severe illness and high attack rates of influenza infection. In Australia, routine seasonal influenza vaccination is currently strongly recommended for all pregnant women and women planning pregnancy, and is provided free of charge for all pregnant women. We sought to determine vaccination coverage, describe the trends and characteristics associated with influenza vaccine uptake and determine the validity of self-reported influenza vaccination in a population of I...
Source: Communicable Diseases Intelligence Quarterly Report - March 11, 2017 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research